Itolizumab – a humanized anti-CD6 monoclonal antibody with a better side effects profile for the treatment of psoriasis

Overview of attention for article published in Clinical, Cosmetic and Investigational Dermatology, April 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

So far, Altmetric has seen 2 patents that reference this research output.